Skip to content

    Cancer Health Center

    Font Size

    Late Effects of Treatment for Childhood Cancer (PDQ®): Treatment - Health Professional Information [NCI] - Subsequent Neoplasms


    Subsequent Neoplasms and Genetic Susceptibility

    Literature clearly supports the role of chemotherapy and radiation in the development of SNs. However, interindividual variability exists, suggesting that genetic variation has a role in susceptibility to genotoxic exposures, or that genetic susceptibility syndrome confers an increased risk of cancer, such as Li-Fraumeni syndrome. Previous studies have demonstrated that childhood cancer survivors with either a family history of cancer, but more so, presence of Li-Fraumeni syndrome, carry an increased risk of developing an SN.[58,59]

    The risk of SNs could potentially be modified by mutations in high-penetrance genes that lead to these serious genetic diseases (e.g., Li-Fraumeni syndrome).[59] However, the attributable risk is expected to be very small because of the extremely low prevalence of mutations in high-penetrance genes.

    Table 1 below summarizes the spectrum of neoplasms, affected genes, and Mendelian mode of inheritance of selected syndromes of inherited cancer predisposition.

    Table 1. Selected Syndromes of Inherited Cancer Predispositiona

    Syndrome Major Tumor Types Affected Gene Mode of Inheritance
    AML = acute myeloid leukemia; MDS = myelodysplastic syndromes; WAGR = Wilms tumor, aniridia, genitourinary anomalies, mental retardation.
    a Adapted from Strahm et al.[60]
    b Dominant in a fraction of patients, spontaneous mutations can occur.
    Adenomatous polyposis of the colon Colon, hepatoblastoma, intestinal cancers, stomach, thyroid cancer APC Dominant
    Ataxia-telangiectasia Leukemia, lymphoma ATM Recessive
    Beckwith-Wiedemann syndrome Adrenal carcinoma, hepatoblastoma, rhabdomyosarcoma, Wilms tumor CDKN1C/NSD1 Dominant
    Bloom syndrome Leukemia, lymphoma, skin cancer BLM Recessive
    Diamond-Blackfan anemia Colon cancer, osteogenic sarcoma, AML/MDS RPS19and otherRPgenes Dominant, spontaneousb
    Fanconi anemia Gynecological tumors, leukemia, squamous cell carcinoma FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG Recessive
    Juvenile polyposis syndrome Gastrointestinal tumors SMAD4/DPC4 Dominant
    Li-Fraumeni syndrome Adrenocortical carcinoma, brain tumor, breast carcinoma, leukemia, osteosarcoma, soft tissue sarcoma TP53 Dominant
    Multiple endocrine neoplasia 1 Pancreatic islet cell tumor, parathyroid adenoma, pituitary adenoma MEN1 Dominant
    Multiple endocrine neoplasia 2 Medullary thyroid carcinoma, pheochromocytoma RET Dominant
    Neurofibromatosis type 1 Neurofibroma, optic pathway glioma, peripheral nerve sheath tumor NF1 Dominant
    Neurofibromatosis type 2 Vestibular schwannoma NF2 Dominant
    Nevoid basal cell carcinoma syndrome Basal cell carcinoma, medulloblastoma PTCH Dominant
    Peutz-Jeghers syndrome Intestinal cancers, ovarian carcinoma, pancreatic carcinoma STK11 Dominant
    Retinoblastoma Osteosarcoma, retinoblastoma RB1 Dominant
    Tuberous sclerosis Hamartoma, renal angiomyolipoma, renal cell carcinoma TSC1/TSC2 Dominant
    von Hippel-Lindau syndrome Hemangioblastoma, pheochromocytoma, renal cell carcinoma, retinal and central nervous tumors VHL Dominant
    WAGR syndrome Gonadoblastoma, Wilms tumor WT1 Dominant
    Wilms tumor syndrome Wilms tumor WT1 Dominant
    Xeroderma pigmentosum Leukemia, melanoma XPA, XPB, XPC, XPD, XPE, XPF, XPG, POLH Recessive
    1 | 2 | 3 | 4 | 5 | 6
    Next Article:

    Today on WebMD

    man holding lung xray
    What you need to know.
    stem cells
    How they work for blood cancers.
    woman wearing pink ribbon
    Separate fact from fiction.
    Colorectal cancer cells
    Symptoms, screening tests, and more.
    Jennifer Goodman Linn self-portrait
    what is your cancer risk
    colorectal cancer treatment advances
    breast cancer overview slideshow
    prostate cancer overview
    lung cancer overview slideshow
    ovarian cancer overview slideshow
    Actor Michael Douglas